NDC 17856-0060-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0060
- Requested NDC
- 17856-0060-01
- Package NDCs from labels
- 17856-0060-1, 17856-0060-3, 17856-0060-2, 17856-0060-4, 17856-0060-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEGESTROL ACETATE ORAL SUSPENSION, USP | ATLANTIC BIOLOGICALS CORP. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0060-1 | Megestrol Acetate | 10 mL in 1 CUP | SUSPENSION | 10 | 3 | |
| 17856-0060-2 | Megestrol Acetate | 20 mL in 1 CUP | SUSPENSION | 20 | 3 | |
| 17856-0060-3 | Megestrol Acetate | 72 in 1 BOX | SUSPENSION | 72 | 3 | |
| 17856-0060-4 | Megestrol Acetate | 50 in 1 BOX | SUSPENSION | 50 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0060 | MEGESTROL ACETATE SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250524_01119031-9943-4afb-8b45-cb71682f0482.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Ailex Pharmaceuticals, LLC | 329655ae-c3c0-46b2-a925-e49777f2076b | 2025-03-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | Meijer, Inc. | 2619be6e-877b-16a2-e063-6394a90a68da | 2025-03-24 | Warnings | F05Q2T2JA0 |
| Stool Softener plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Meijer, Inc. | 261a88d6-87d2-7544-e063-6294a90a2e94 | 2025-03-24 | Warnings | F05Q2T2JA0 |
| CVS Health Stool Softener Plus stimulant laxative Softgel | DOCUSATE SODIUM, SENNOSIDES | CVS Pharmacy, Inc | 2881d83d-9929-677a-e063-6394a90a0424 | 2025-03-19 | Warnings | F05Q2T2JA0 |
| Alka-Seltzer Heartburn Relief Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer Healthcare LLC | dc1641f8-54c2-0d86-e053-2995a90a1dce | 2025-03-11 | Warnings | 2968PHW8QP |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | OJ245FE5EU 1Q73Q2JULR |
| Curist Hemorrhoid Fissure Relief | LIDOCAINE | Little Pharma, Inc | 2fb02b00-acdb-5184-e063-6294a90ae1c8 | 2025-03-06 | Warnings | PDC6A3C0OX |
| Thera Plus Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE | FOURSTAR GROUP USA, INC. | 87143a7a-7b2d-4b67-afda-2355697e7300 | 2025-03-04 | Warnings | PDC6A3C0OX |
| STOOL SOFTENER | DOCUSATE SODIUM | Bi-Mart | 6589d373-0696-44c2-a9d4-a76e45526c5a | 2025-03-01 | Warnings | F05Q2T2JA0 |
| Alcostat | TARAXACUM OFFICINALE, AVENA SATIVA, PASSIFLORA INCARNATA, AURUM METALLICUM, CAPSICUM ANNUUM, CHELIDONIUM MAJUS, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NOX VOMICA, QUERCUS GLANDIUM SPIRITUS, SULPHURICUM ACIDUM, ETHYLICUM, CARCINOSIN, SACCHARUM OFFICINALE | Energique, Inc. | 77daea02-3c32-4ba3-a7a8-af79b13ddc06 | 2025-02-27 | Warnings | C151H8M554 |
| Blink Nourish Dry Eye | GLYCERIN | Bausch & Lomb Incorporated | cf2b4e19-af0a-472e-9a2d-9b4fa3e9c9a4 | 2025-02-25 | Warnings | PDC6A3C0OX |
| Megestrol Acetate | MEGESTROL ACETATE | Strides Pharma Science Limited | 8ec70070-da70-4a38-9d58-cf2278517661 | 2025-02-24 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Se-Natal 19 | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE AND DOCUSATE SODIUM | Seton Pharmaceuticals | 635104e6-6a53-4684-ac9a-7ac31b33083d | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | F05Q2T2JA0 |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Omnivium Pharmaceuticals LLC | 9067c301-74f9-457a-9b0f-b7e9b06a3508 | 2025-02-15 | Warnings, Adverse reactions | OJ245FE5EU |
| Hydropure Lubricating Eye Drops | GLYCERIN | OTE North America | 17f5b6e5-dc14-45c7-e063-6294a90af43d | 2025-02-14 | Warnings | PDC6A3C0OX |
| Stool Softener and Stimulant Laxative | DOCUSATE SODIUM, SENNOSIDES | H-E-B | c19280c2-f968-b582-e053-2995a90a9bd3 | 2025-02-14 | Warnings | F05Q2T2JA0 |
| STOOL SOFTENER-STIMULANT LAXATIVE | STOOL SOFTENER-STIMULANT LAXATIVE | Kroger Company | a22c9f95-e3a9-bfd3-e053-2995a90a3c66 | 2025-02-13 | Warnings | F05Q2T2JA0 |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | KROGER | a187045c-c9d6-592a-e053-2995a90adb83 | 2025-02-10 | Warnings | F05Q2T2JA0 |
| SENNA TIME S | DOCUSATE SODIUM-SENNOSIDES | TIME CAP LABORATORIES, INC | dc491692-8d3a-4ccd-a17d-4c630f122595 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| SENNOSIDES AND DOCUSATE SODIUM | SENNOSIDES AND DOCUSATE SODIUM | TIME CAP LABORATORIES, INC | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 2025-02-08 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.